ライフサイエンスコーパス: venture

1 both a time-consuming and financially-taxing venture.

2 GlaxoSmithKline, Medicines for Malaria Venture.

3 rimates has been particularly useful in this venture.

4 enesis is the ultimate multidisciplinary (ad)venture.

5 riologist to grasp the scale and pace of the venture.

6 this 'short-changing' will erode cooperative ventures.

7 the availability of physicians for outreach ventures.

8 rapidly, typically before a wayward cell has ventured a fraction of a micron.

9 ited evidence, well over 150 physicians have ventured a perplexing variety of diagnoses of his illnes

10 s and referring to recent mouse studies, and ventures a few extrapolations into the future of this en

11 technology) of the physician entrepreneur's venture and the role that the physician entrepreneur des

12 reates opportunities for firms to form joint ventures and slide down their learning curves more effic

13 lex and long-term nature of this cooperative venture are summarized.

14 it data were obtained from Verispan, a joint venture between Quintiles Transnational and McKesson.

15 eers, chemists and materials scientists have ventured beyond experiments that merely mimic what happe

16 These approaches rarely have ventured beyond traditional disciplinary boundaries.

17 sed number of researchers, research funding, venture capital and the number of start-ups.

18 rs and be wary of conflicts of interest with venture capital entrepreneurs-in-residence.

19 s the benefits and drawbacks of funding from venture capital firms, grants, friends and family, angel

20 gher income, higher trust, lower taxes, more venture capital investment, and lower regulatory burdens

21 ation' holders, which are lower than typical venture-capital hurdle rates but attractive to pension f

22 pharmacologists together with pharmaceutical venture capitalist companies.

23 ities, start-up firms, corporate giants, and venture capitalists play a major role in facilitating th

24 6, he was named to the Midas List of leading venture capitalists, and, in 2013, he was recognized by

25 ey requirements of the Medicines for Malaria Venture drug candidate profiles.

26 vestors to consider early-stage life science ventures, especially in the context of a maturing biotec

27 an statisticians as a fruitful and rewarding venture for advancing applied research in parasite epide

28 echnology companies are struggling to obtain venture funds.

29 cal Trial Partnership, Medicines for Malaria Venture (Geneva, Switzerland), UK Medical Research Counc

30 Key elements of the synthetic venture include a catalytic enantioselective biaryl coup

31 ths and weaknesses of their data before they venture into further analysis.

32 rch on O2(*-) so as to enable researchers to venture into future research.

33 nts a vast opportunity for those prepared to venture into new territories of drug discovery.

34 data, and we present promising solutions and venture into potential future developments.

35 esearchers often need to leave the bench and venture into the field.

36 To encourage more cell biologists to venture into the realm of translational research on a re

37 need to be re-examined, and researchers are venturing into new regimes of optical physics.

38 We are venturing into the unknown with climate, and its associa

39 Lack of success with this venture is a testament to the difficulty of accurately p

40 tion of inhibitors from the Malaria Medicine Venture Malaria Box against the interaction of PfAtg8 wi

41 which according to the Medicines for Malaria Venture (MMV) met the efficacy and drug metabolism and p

42 result, when scientists and engineers first venture out of the laboratory or library with the goal o

43 re Partners, where he leads the Life Science Venture practice.

44 ss creation, the matching of entrepreneurial ventures to investors is critically important.

45 eveloping global partners and private-public ventures to meet infrastructure and funding challenges,

46 protein target for the Medicines of Malaria Venture validated collection of parasite proliferation i

47 Central to this venture was recognition and deployment of a key strategy

48 who might therefore be useful in cooperative ventures)-was reflected in an increased negativity of N1

49 The field even allows us to venture where no chapters have yet been written.

50 Some of our older ventures, where ideas about pattern recognition were fir

51 s stem from an IUPAC-IUBMB-IUPAB inter-union venture with the direct involvement of ICSU and CODATA.

52 s being driven by MMV (Medicines for Malaria Venture), with a number of projects recently reaching th